REFI
GYRE icon

Requisite Energy Fund I’s Gyre Therapeutics GYRE Stock Holding History

Requisite Energy Fund I’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$256K Buy
+4,333
New +$320K 0.1% 51

Other funds holding GYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Requisite Energy Fund I's GYRE Position: Q4 2018 in Review

Requisite Energy Fund I opened a new position in Gyre Therapeutics (GYRE) in Q4 2018: 4,333 shares worth $256K. The stake represents 0.1% of the portfolio and ranks #51 among its holdings.

65 funds tracked by Wall St. Rank hold GYRE as of Q4 2018.

  • Requisite Energy Fund I held 4,333 shares of Gyre Therapeutics worth $256K as of Q4 2018.
  • Gyre Therapeutics was a new Requisite Energy Fund I position in Q4 2018.
  • Gyre Therapeutics made up 0.1% of Requisite Energy Fund I's portfolio in Q4 2018, its #51 holding.
  • 65 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2018.

Based on Requisite Energy Fund I's 13F filing for Q4 2018, filed 14 Feb 2019.